Evidence

Proven results published by top healthcare companies

The world’s largest healthcare companies use AdhereTech for tens of thousands of patients. These firms will only use technologies that are proven to be effective by the most reliable sources. That is why AdhereTech is especially proud to share results that have been published by similar large healthcare companies, for their actual patients in the real world. We’re especially proud that our results are consistent across different patient populations, pharmacies, medications, and disease states.

Avella Specialty Pharmacy

UnitedHealth Group

“AdhereTech improves adherence and generates 1-2 additional fills of medication per patient per year, across multiple specialty medications and diseases”

view published report
  • "Averaged across all patients and programs… AdhereTech has improved duration on therapy by 26%, fill rates by 9%, and dose-level adherence by 15%."
  • "Patient feedback is overwhelmingly positive, with the average patient satisfaction rating at 4.7 out of 5."
  • "Avella currently uses the AdhereTech program for five specialty medications, in programs with four different pharmaceutical manufacturers."

Diplomat Pharmacy

Largest Independant Pharmacy in the US

“The average patient using AdhereTech bottles experienced more than one additional medication fill [annually]”

view published report
  • "Over a year, the average patient using AdhereTech bottles experienced a 12 percent higher patient retention rate"
  • "19 fewer gap days [annually] (time without medication between fills)"
  • "Adherence and persistence improvements for patients using AdhereTech"

US Bioservices

AmerisourceBergen

“Patients using AdhereTech Smart Pill Bottles through US Bioservices stayed on therapy longer, refilled prescriptions more frequently”

view published report
  • "Patients new to therapy who began treatment with the Smart Pill Bottle stayed on therapy for 1.5 additional months and had 1.3 additional fills dispensed."
  • "Consistently, patients continuing on a therapy had 1.2 additional fills dispensed compared to their peers not in the program."
  • "[AdhereTech] is directly correlated to more positive outcomes."

Avella Specialty Pharmacy

UnitedHealth Group Clinical Use-Case

“Significantly improved patient adherence"

view published report
  • "Median adherence rate of [AdhereTech] patients was 100% adherence compared to 90.75% in the [non-AdhereTech] control group"
  • "Patients in the [AdhereTech] arm took 83% of doses within the recommended window, compared with 22% in the control arm"
  • "Positive feedback from [patients]"
  • "Pharmacists only had to make one intervention for patients [using AdhereTech]... [compared to] 10 interventions for patients [not using AdhereTech]"
Most of the AdhereTech’s data reports are confidential, but some non-confidential reports can be shared with relevant parties, upon request.
Please contact us for more information.